April 29

2015

Q&A: Mayer Brown's Brian Nolan on strategy behind drug patent challenges

Reuters (subscription required)

Home
News
Q&A: Mayer Brown's Brian Nolan on strategy behind drug patent challenges

Related People

Brian W. Nolan

In this Q&A interview, Intellectual Property partner Brian Nolan (New York) discusses strategy behind drug patent challenges.

Related Capabilities

Practices –

Industries –

Life Sciences

News

May 11

2021

Mayer Brown advises Standard Profil on debut high-yield bond offering
April 22

2021

Mayer Brown advises Reliance Industries of India on acquisition of Stoke Park Estates
April 19

2021

Mayer Brown represents Marlin Business Services in sale to affiliates of HPS Investment Partners
April 15

2021

Mayer Brown represents Lone Star’s Caliber Home Loans in $1.675B sale to New Residential Investment
March 31

2021

Drones and copyright

Asia IP (by subscription only)